Impairment of erythroid and megakaryocytic differentiation by a leukemia-associated and t(9;9)-derived fusion gene product, SET/TAF-Iβ-CAN/ Nup214

Journal of Cellular Physiology

Volumn 214, Issue 2, 2008, Pages 322-333

  Saito, Shoko ^a   Nouno, Kaoru ^a   Shimizu, Ritsuko ^a   Yamamoto, Masayuki ^a   Nagata, Kyosuke ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN; PROTEIN SET CAN; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME TRANSLOCATION 9; CONTROLLED STUDY; ERYTHROID CELL; HEMATOPOIETIC CELL; LEUKEMIA; LEUKEMOGENESIS; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENOMEGALY; THROMBOCYTOPENIA; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, PAIR 9; DNA, COMPLEMENTARY; ERYTHROID PROGENITOR CELLS; HEMATOPOIESIS; HUMANS; LEUKEMIA; MEGAKARYOCYTES; MICE; MICE, TRANSGENIC; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

MUS MUSCULUS;

EID: 37349080230     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21199     Document Type: Article

References (30)

1. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
2. D'Angelo MA, Hetzer MW. 2006. The role of the nuclear envelope in cellular organization. Cell Mol Life Sci 63:316-332.
3. Fornerod M, Boer J, van Baal S, Jaegle M, von Lindern M, Murti KG, Davis D, Bonten J, Buijs A, Grosveld G. 1995, Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 10:1739-1748.
4. Fornerod M, Boer J, van Baal S, Morreau H, Grosveld G. 1996. Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene 13:1801-1808.
5. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, Bosly A, Heimann P, Uyttebroeck A, Mentens N, Somers R, MacLeod RA, Drexler HG, Look AT, Gilliland DG, Michaux L, Vandenberghe P, Wlodarska I, Marynen P, Hagemeijer A. 2004. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36:1084-1089.
6. Kandilci A, Mientjes E, Grosveld G. 2004. Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia 18:337-340.
7. Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, van Deursen JM. 1999. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol 19:764-776.
8. Kato K, Miyaji-Yamaguchi M, Okuwaki M, Nagata K. 2006. Histone acetylation-independent transcription stimulation by a histone chaperone. Nucleic Acids Res 36:705-715.
9. Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. 2001. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 20:350-361.
10. Look AT. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
11. Moore MA. 2005. Converging pathways in leukemogenesis and stem cell self-renewal. Exp Hematol 33:719-737.
12. Nagata K, Kawase H, Handa H, Yano K, Yamasaki M, Ishimi Y, Okuda A, Kikuchi A, Matsumoto K. 1995. Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci USA 92:4279-4283.
13. Nagata K, Saito S, Okuwaki M, Kawase H, Furuya A, Kusano A, Hanai N, Okuda A, Kikuchi A. 1998. Cellular localization and expression of template-activating factor I in different cell types. Exp Cell Res 240:274-281.
14. Nakamura T. 2005. NUP98 fusion in human leukemia: Dysregulation of the nuclear pore and homeodomain proteins. Int J Hematol 82:21-27.
15. Nishida S, Hosen N, Shirakata T, Kanato K, Yanagihara M, Nakatsuka S, Hoshida Y, Nakazawa T, Harada Y, Tatsumi N, Tsuboi A, Kawakami M, Oka Y, Oji Y, Aozasa K, Kawase I, Sugiyama H. 2006. AML1-ETO rapidly induces acute myeloblasts leukemia in cooperation with the Wilms tumor gene, WT1. Blood 107:3303-3312.
16. Okuwaki M, Nagata K. 1998. Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template. J Biol Chem 273:34511-34518.
17. Onodera K, Takahashi S, Nishimura S, Ohta J, Motohashi H, Yomogida K, Hayashi N, Engel JD, Yamamoto M. 1997. GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc Natl Acad Sci USA 94:4487-4492.
18. Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, Ito Y. 1999. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93:1817-1824.
19. Rosati R, La Starza R, Barba G, Gorello P, Pierini V, Matteucci C, Roti G, Crescenzi B, Aloisi T, Aversa F, Martelli MF, Mecucci C. 2007, Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. Haematologica 92:232-235.
20. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, Akashi K, Fiering S, Tenen DG. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36:624-630.
21. Roumier C, Eclache V, Imbert M, Davi F, MacIntyre E, Garand R, Talmant P, Lepelley P, Lai JL, Casasnovas O, Maynadie M, Mugneret F, Bilhou-Naberra C, Valensi F, Radford I, Mozziconacci MJ, Arnoulet C, Duchayne E, Dastugue N, Cornillet P, Daliphard S, Garnache F, Boudjerra N, Jouault H, Fenneteau O, Pedron B, Berger R, Flandrin G, Fenaux P, Preudhomme C. 2003. M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: A report of 59 cases by the Groupe Francais d'Hematologie Cellulaire (GFHC) and the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood 101:1277-1283.
22. Saito S, Miyaji-Yamaguchi M, Nagata K. 2004. Aberrant intracellular localization of SET-CAN fusion protein, associated with a leukemia, disorganizes nuclear export. Int J Cancer 111:501-507.
23. Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. 2001. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104:119-130.
24. Shimizu R, Kuroha T, Ohneda O, Pan X, Ohneda K, Takahashi S, Philipsen S, Yamamoto M. 2004. Leukemogenesis caused by incapacitated GATA-1 function. Mol Cell Biol 24:10814-10825.
25. Shimoyama T, Kato K, Miyaji-Yamaguchi M, Nagata K. 2005. Synergistic action of MLL, a TRX protein with template activating factor-I, a histone chaperone. FEBS Lett 579:757-762.
26. Suzuki N, Suwabe N, Ohneda O, Obara N, Imagawa S, Pan X, Motohashi H, Yamamoto M. 2003a. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood 102:3575-3583.
27. Suzuki T, Muto S, Miyamoto S, Aizawa K, Horikoshi M, Nagai R. 2003b. Functional interaction of the DNA-binding transcription factor 5p1 through its DNA-binding domain with the histone chaperone TAF-I. J Biol Chem 278:28758-28764.
28. von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G. 1992a. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 12:1687-1697.
29. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G. 1992b. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: Characterization of the set gene. Mol Cell Biol 12:3346-3355.
30. Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K, Zhang DE. 2001. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 98:10398-10403.